Regeneron Pharmaceuticals (REGN) is a biotechnology company in the Health Care sector. Listed on the NASDAQ, Regeneron Pharmaceuticals is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $601.65.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $601.65 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | 7.65% |
| Risk / Std Dev (Annualized) | 30.80% |
| Sharpe Ratio (rf=4.5%) | 0.10 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Biotechnology
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of 7.65% with an annualized volatility of 30.80%. The Sharpe ratio of 0.10 (assuming 4.5% risk-free rate) indicates below-average risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 63.08B |
| Enterprise Value | 55.16B |
| Trailing P/E | 14.69 |
| Forward P/E | 11.19 |
| Price to Book | 1.95 |
| Price to Sales | 4.23 |
| EV/Revenue | 3.7 |
| EV/EBITDA | 12.59 |
| Profitability | | | Profit Margin | 29.65% | | Operating Margin | 20.66% | | ROE | 14.55% | | ROA | 6.13% |
| Growth | | | Revenue Growth | 19.0% | | Earnings Growth | -7.2% |
| Dividend | | | Dividend Yield | 62.0% | | Payout Ratio | 8.74% |
| Financial Health | | | Total Revenue | 14.92B | | Total Debt | 2.71B | | Total Cash | 8.75B | | Free Cash Flow | 3.27B | | Operating Cash Flow | 5.01B |
| Price & Technical | | | 52W High | $821.11$ | | 52W Low | $503.25$ | | 50-Day Avg | $701.78$ | | 200-Day Avg | $696.08$ | | Beta | 0.24 | | Shares Outstanding | 0.1B | | Float Shares | 0.1B | | Insider Holdings | 2.03% | | Institutional Holdings | 92.25% | | Short Ratio | 2.6 | | Short % of Float | 3.03% |
| Analyst Targets | | | Target High | $1000.0$ | | Target Low | $641.0$ | | Target Mean | $833.31$ | | Target Median | $852.5$ | | # of Analysts | 28 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.